"Adiponectin Paradox" and Cancer Risk: Is It Time for a Reevaluation of the Beneficial Effect of this Adipokine? Frittitta L, Tumminia A. J Clin Endocrinol Metab 2020;105.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Frittitta L, Tumminia A. "Adiponectin Paradox" and Cancer Risk: Is It Time for a Reevaluation of the Beneficial Effect of this Adipokine? J Clin Endocrinol Metab 2020;105.
PMID: 32270197